Histamine Analogue — Vestibular
Pregnancy: Avoid in pregnancy — limited safety data
Betahistine
Brand names: Serc
Adult dose
Dose: 8-16 mg three times daily
Route: Oral
Frequency: Three times daily with food
Max: 48 mg/day
Take with food to reduce GI side effects. Treatment may take 2-3 months for full effect in Meniere's disease
Paediatric dose
Dose: Seek specialist opinion N/A/kg
Route: Oral
Frequency: Seek specialist opinion
Max: Seek specialist opinion
Seek specialist opinion
Dose adjustments
Renal
No adjustment required
Hepatic
Use with caution in severe hepatic impairment
Paediatric weight-based calculator
Seek specialist opinion
Clinical pearls
- Licensed for Meniere's disease (vertigo, tinnitus, hearing loss) — efficacy is modest and evidence is mixed; NICE does not strongly endorse but it is widely used in ENT practice
- Acts as a weak partial agonist at H1 receptors and antagonist at H3 receptors in the inner ear — improves microcirculation and reduces endolymphatic pressure
- Vestibular neuritis (acute): vestibular suppressants (betahistine, cinnarizine) can mask compensation — physiotherapy-led vestibular rehabilitation is preferred for long-term recovery
- Well-tolerated in elderly — low anticholinergic burden, no significant CNS effects, no falls risk (advantage over prochlorperazine and cinnarizine)
- May take 2-3 months for effect in Meniere's — counsel patients on expectations; review at 6 months
Contraindications
- Phaeochromocytoma (theoretical risk — histamine agonism)
- Peptic ulcer disease (active)
Side effects
- Headache (common)
- Nausea and GI upset (take with food)
- Pruritus and urticaria (rare hypersensitivity)
- Rarely bronchoconstriction (use with caution in asthma)
Interactions
- Antihistamines (theoretical antagonism — avoid combination)
- MAOIs (theoretical interaction)
Monitoring
- Symptom response (vertigo frequency, tinnitus, hearing)
- GI tolerability
Reference: BNFc; BNF 90; NICE Evidence Review (Betahistine for Meniere's); Cochrane Review (betahistine); BSA Meniere's guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5